Belgium· BE-AMP-SAM017211-00
Bleu Patente V Guerbet 2.5 g/100 ml
A patentblau v product containing sodium patent blue v, registered in Belgium by Guerbet. The same ATC class is registered in 4 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Patentblau v is registered in 4 of 19 countries.
Countries holding a registration under ATC V04CX09 (patentblau v), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Patentblau v · ATC V04CX09
4 / 19 countries
- Belgiumprice
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Sodium Patent Blue V
- Manufacturer
- Guerbet
- Country
- Belgium (BE)
- ATC code
- V04CX09
- ATC class
- Patentblau V
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0835041
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Patentblau v in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAZUL PATENTE AZULTIS 25 MG/ML SOLUCION INYECTABLE EFGProvepharm
- GermanyPatentblau V AzultisProvepharm Sas
- United KingdomPatent blue V 2.5% solution for injection 2ml ampoulesImported (France)
- FranceBLEU PATENTE V SODIQUE GUERBET 2,5 POUR CENT, solution injectableGUERBET
- NorwayBleu Patente V guerbetGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Patentblau V Azultis
- Germany · Patentblau V Azultis, Patentblau V Guerbet
- Spain · Azul Patente Azultis
- France · Bleu Patente V Sodique Azultis, Bleu Patente V Sodique Guerbet
- Hungary · Patent Blue V Sodium Azultis Provepharm, Patentblue Guerbet
- Luxembourg · Bleu Patenté V Guerbet
- Netherlands · Bleu Patente V Guerbet, Patentblauw V Azultis
- Slovakia · Patentblau V Guerbet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2286d8c1-050e-4f87-a53a-5b5110ae9460 GET /v1/drugs/2286d8c1-050e-4f87-a53a-5b5110ae9460?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Bleu Patente V Guerbet 2.5 g/100 ml",
"name_fr": "Bleu Patente V Guerbet 2.5 g/100 ml",
"name_nl": "Bleu Patente V Guerbet 2.5 g/100 ml",
"amp_code": "SAM017211-00",
"strengths": [
"50.0000",
"1.0000",
"12.0000"
],
"pack_count": 1,
"substances": [
"Sodium Patent Blue V",
"Patent Blue V",
"Disodium Hydrogen Phosphate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Patent Blue",
"authorisation_numbers": [
"BE017211"
]
}See everything about patentblau v.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.